ArticleBlood and lymphatic cancer : targets and therapy2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study.
Na Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.